Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective Tissue

Explore clinical trials studying Neoplasms, Connective Tissue. Study availability and eligibility vary by location and protocol.

1,267 public trials 270 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective Tissue trial results

Active, Not Recruiting

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

NCT06068075

Conditions
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue, +19 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

NCT05804045

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • Duke University Medical Center Durham, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View all 40 locations
View Trial Details
Active, Not Recruiting

Trial Comparing Treatment Strategies in Dupuytren's Contracture

NCT03192020

Conditions
Connective Tissue Diseases, Contracture, Dupuytren Contracture, +10 more
Locations
  • Central Hospital of Central Finland Jyväskylä, Central Finland, Finland
  • Oulu University hospital Oulu, North Ostrobothnia, Finland
  • Kuopio University hospital Kuopio, Northern Savonia, Finland
  • Tampere University Hospital Tampere, Pirkanmaa, Finland
View Trial Details
Active, Not Recruiting

Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate

NCT00265798

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
View Trial Details
Active, Not Recruiting

AG-120 in People With IDH1 Mutant Chondrosarcoma

NCT04278781

Conditions
Chondrosarcoma, Chondrosarcoma, Grade 2, Chondrosarcoma, Grade 3, +14 more
Locations
  • Johns Hopkins Hospital (Data Collection Only) Baltimore, Maryland, United States
  • Columbia University (Specimen Analysis Only) New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • The Ohio State University (Data Collection Only) Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

NCT05836571

Conditions
Histiocytoma, Histiocytoma, Malignant Fibrous, Locally Advanced Extraskeletal Myxoid Chondrosarcoma, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
View all 27 locations
View Trial Details

Related conditions